Rankings
▼
Calendar
ELVN FY 2020 Earnings — Enliven Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ELVN
Enliven Therapeutics, Inc.
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$9M
Net Income
-$19M
EPS (Diluted)
$-4.31
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$130,000
Balance Sheet
Total Assets
$91M
Total Liabilities
$6M
Stockholders' Equity
$84M
Cash & Equivalents
$48M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$33,000
+100.0%
Operating Income
-$9M
-$24M
+61.4%
Net Income
-$19M
-$23M
+19.2%
← Q4 2019
All Quarters
Q1 2020 →